Procter & Gamble holder to sell 72,186 shares

The Procter & Gamble Company shareholder filed a notice to sell 72,186 shares of common stock, with an aggregate market value of $11,007,643.14.

Accepted by SEC EDGAR 02/03/2026 - 02:37 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

The Procter & Gamble Company shareholder filed a notice to sell 72,186 shares of common stock, with an aggregate market value of $11,007,643.14.

The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE around February 4, 2026, and were acquired that same day by exercising a stock option for cash. Shares outstanding were 2,324,000,685 common shares at the time referenced.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale did Procter & Gamble (PG) disclose in this Form 144?

A Procter & Gamble shareholder plans to sell 72,186 shares of common stock. The filing lists an aggregate market value of $11,007,643.14, indicating a sizable planned transaction under Rule 144 through a broker on a national exchange.

When are the 72,186 Procter & Gamble (PG) shares expected to be sold?

The filing indicates an approximate sale date of February 4, 2026. This date reflects when the 72,186 Procter & Gamble common shares may be sold under Rule 144 on the NYSE through the designated broker, subject to market conditions and applicable regulations.

How were the Procter & Gamble (PG) shares in this Form 144 acquired?

The 72,186 Procter & Gamble shares were acquired on February 4, 2026 by exercising a stock option. The acquisition is described as an “Exercise and Sale of Stock Option,” with the purchase price paid in cash to The Procter & Gamble Company.

Which broker is handling the planned Procter & Gamble (PG) share sale?

The filing states that Morgan Stanley Smith Barney LLC Executive Financial Services will handle the sale. The broker’s office is listed at 1 New York Plaza, 38th Floor, New York, NY 10004, and the transaction is expected to occur on the NYSE.

How many Procter & Gamble (PG) shares were outstanding when this Form 144 was filed?

The document reports 2,324,000,685 Procter & Gamble common shares outstanding. This figure provides context for the planned Rule 144 sale of 72,186 shares, helping investors understand the relative scale of the proposed transaction versus total shares.

What type of security is being sold under this Procter & Gamble (PG) Form 144?

The filing covers sales of Procter & Gamble common stock. It identifies the security class as “Common Stock,” specifies 72,186 shares to be sold, and notes trading on the NYSE via Morgan Stanley Smith Barney LLC as the executing broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001623622
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROCTER & GAMBLE Co
SEC File Number	001-00434
Address of Issuer	ONE PROCTER & GAMBLE PLAZA CINCINNATI OHIO 45202
Phone	5139831100
Name of Person for Whose Account the Securities are To Be Sold	Coombe Gary A
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	72186	11007643.14	2324000685	02/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/04/2026	Exercise and Sale of Stock Option	The Procter & Gamble Company			72186	02/04/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	1) Based on the average high and low price on February 2, 2026. 2) Acquisition and payment dates for stock option exercise will be the same.
Date of Notice	02/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Wednesday Shipp, attorney-in-fact for Gary A. Coombe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)